Literature DB >> 14535866

Antibiotic therapy--rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue.

Kurt G Naber1, Fritz Sörgel.   

Abstract

The theoretical background of drug penetration into the prostate is outlined, emphasizing the phenomenon of ion-trapping and the role of nonionic diffusion of weak acids, bases and amphoteric drugs across biological membranes with a pH gradient. Determination of drug concentrations in human prostatic secretion are problematic because of possible urinary contamination. Studies have been carried out mainly in healthy volunteers. The results have to be interpreted with caution, if not care was taken to rule out or at least identify urinary contamination. Analysing the concentrations of various fluoroquinolones in prostatic and seminal fluid as well as in prostatic tissue, it becomes obvious that the fluoroquinolones differ not only in plasma concentrations but also in their penetration ability to these sites. In spite of intensive investigations, our knowledge is still limited concerning the mechanisms that govern the transport of antibiotic drugs into and their activity in the various prostatic compartments and how the findings can be applied clinically. Nevertheless, overall the concentrations at the site of infection of most of the fluoroquinolones should be sufficient for the treatment of chronic bacterial prostatitis and vesiculitis caused by susceptible pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14535866

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  15 in total

1.  Differential characteristics of healthcare-associated compared to community-acquired febrile urinary tract infections in males.

Authors:  A Smithson; J Ramos; M T Bastida; S Bernal; N Jove; E Niño; N Msabri; R Porrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-25       Impact factor: 3.267

Review 2.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

Review 3.  Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.

Authors:  Robin R Chamberland
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

Review 4.  Reducing infection rates after prostate biopsy.

Authors:  Florian M E Wagenlehner; Adrian Pilatz; Przemyslaw Waliszewski; Wolfgang Weidner; Truls E Bjerklund Johansen
Journal:  Nat Rev Urol       Date:  2014-01-14       Impact factor: 14.432

5.  Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction.

Authors:  Vittorio Magri; Emanuele Montanari; Višnja Škerk; Alemka Markotić; Emanuela Marras; Antonella Restelli; Kurt G Naber; Gianpaolo Perletti
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

6.  Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection.

Authors:  A Smithson; C Chico; J Ramos; C Netto; M Sanchez; J Ruiz; R Porron; M T Bastida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-15       Impact factor: 3.267

7.  Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.

Authors:  Felipe K Hurtado; Benjamin Weber; Hartmut Derendorf; Guenther Hochhaus; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

Review 8.  New therapies in chronic prostatitis.

Authors:  Nivedita Bhatta Dhar; Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

9.  Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients.

Authors:  Zhi-Chao Zhang; Feng-Shuo Jin; Dong-Ming Liu; Zhou-Jun Shen; Ying-Hao Sun; Ying-Lu Guo
Journal:  Asian J Androl       Date:  2012-08-06       Impact factor: 3.285

10.  Rectal swab testing before prostate biopsy: experience in a VA Medical Center urology practice.

Authors:  I Cook; J B Angel; P L Vera; J Demos; D Preston
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-08-11       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.